doi: 10.1016/j.vaccine.2009.10.015.
Epub 2009 Oct 22.
Alphavirus replicon particle vaccines developed for use in humans induce high levels of antibodies to influenza virus hemagglutinin in swine: proof of concept
Affiliations
- PMID: 19853679
- DOI: 10.1016/j.vaccine.2009.10.015
Item in Clipboard
Alphavirus replicon particle vaccines developed for use in humans induce high levels of antibodies to influenza virus hemagglutinin in swine: proof of concept
Vaccine.
.
Abstract
A propagation-defective, single-cycle, alphavirus replicon particle (RP) system was used to produce two vaccines against human influenza virus A/Wyoming/03/2003 (H3N2). One vaccine was prepared from Venezeulan equine encephalitis virus (VEEV) strain 3014 and the other from VEEV strain TC-83. Both vaccines induced high antibody titers to the influenza hemagglutinin (HA) protein and illustrated the potential of using alphavirus RP influenza vaccines in swine.
Similar articles
-
Replicon particle vaccine protects swine against influenza.Comp Immunol Microbiol Infect Dis. 2010 Dec;33(6):e99-e103. doi: 10.1016/j.cimid.2010.05.002. Epub 2010 Jun 17. Comp Immunol Microbiol Infect Dis. 2010. PMID: 21094422
-
Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.Virology. 1997 Dec 22;239(2):389-401. doi: 10.1006/viro.1997.8878. Virology. 1997. PMID: 9434729
-
Safety, immunogenicity, and efficacy of an alphavirus replicon-based swine influenza virus hemagglutinin vaccine.Vaccine. 2012 Mar 2;30(11):1944-50. doi: 10.1016/j.vaccine.2012.01.030. Epub 2012 Jan 23. Vaccine. 2012. PMID: 22269873
-
Changing perspective on immunization against influenza.Vaccine. 2007 Apr 20;25(16):3062-5. doi: 10.1016/j.vaccine.2007.01.030. Epub 2007 Jan 19. Vaccine. 2007. PMID: 17276554 Review.
-
[Protection against influenza by genetically engineered vaccines].Nihon Rinsho. 2000 Nov;58(11):2313-20. Nihon Rinsho. 2000. PMID: 11225323 Review. Japanese.
Cited by
-
Assessment of Immune Responses to a Trivalent Pichinde Virus-Vectored Vaccine Expressing Hemagglutinin Genes from Three Co-Circulating Influenza A Virus Subtypes in Pigs.Vaccines (Basel). 2023 Dec 2;11(12):1806. doi: 10.3390/vaccines11121806. Vaccines (Basel). 2023. PMID: 38140210 Free PMC article.
-
A polyprotein-expressing salmonid alphavirus replicon induces modest protection in atlantic salmon (Salmo salar) against infectious pancreatic necrosis.Viruses. 2015 Jan 19;7(1):252-67. doi: 10.3390/v7010252. Viruses. 2015. PMID: 25606973 Free PMC article.
-
Polysaccharide-based chromatographic adsorbents for virus purification and viral clearance.J Pharm Anal. 2020 Aug;10(4):291-312. doi: 10.1016/j.jpha.2020.01.002. Epub 2020 Jan 13. J Pharm Anal. 2020. PMID: 32292625 Free PMC article. Review.
-
Viral vector-based influenza vaccines.Hum Vaccin Immunother. 2016 Nov;12(11):2881-2901. doi: 10.1080/21645515.2016.1210729. Epub 2016 Jul 25. Hum Vaccin Immunother. 2016. PMID: 27455345 Free PMC article. Review.
-
Immunization with a suicidal DNA vaccine expressing the E glycoprotein protects ducklings against duck Tembusu virus.Virol J. 2018 Sep 14;15(1):140. doi: 10.1186/s12985-018-1053-0. Virol J. 2018. PMID: 30217161 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
